Related Experiment Video

Updated: Oct 2, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

[Status and problems of the treatment of metastatic rectal cancer]

M Lehnert

    Acta Medica Austriaca. Supplement
    |January 1, 1979
    PubMed

    Abstract:

    The results of chemotherapy in colorectal carcinoma are disappointing and therefore the treatment of metastatic rectal carcinoma, is problematic. 19 patients were treated with 5-FU, CCNU and Vincristin, the response rate was 26.3%, the median duration of remission 3.8 months.

    More Related Videos

    Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
    12:45

    Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

    Published on: February 12, 2022

    Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
    04:22

    Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

    Published on: March 3, 2023

    Related Experiment Videos

    Last Updated: Oct 2, 2026

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
    08:54

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

    Published on: May 8, 2018

    Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
    12:45

    Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

    Published on: February 12, 2022

    Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
    04:22

    Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

    Published on: March 3, 2023

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cooling effect of evaporative misters in outdoor restaurant areas: case study of Novi Sad, Serbia.

    International journal of biometeorology·2026

    The Pattern of Sensitization Influences Exhaled and Nasal Nitric Oxide Levels in Young Adults.

    Advances in experimental medicine and biology·2020

    Case report-delayed splenic rupture in combination with medial femoral neck fracture after low energy trauma. Development of hemorrhagic shock 5 days after hip prosthesis due to a rare cause.

    Trauma case reports·2018

    Training-induced changes in physical performance can be achieved without body mass reduction after eight week of strength and injury prevention oriented programme in volleyball female players.

    Biology of sport·2017

    Muscular and neuromuscular control following soccer-specific exercise in male youth: Changes in injury risk mechanisms.

    Scandinavian journal of medicine & science in sports·2016

    Real-time PCR probe optimization using design of experiments approach.

    Biomolecular detection and quantification·2016

    [Treatment of residual disease in chronic myeloid leukemia with STI-571 (Glivec)].

    Acta medica Austriaca. Supplement·2003

    [Cell proliferation and cell death in disseminated tumor cells].

    Acta medica Austriaca. Supplement·2003

    [Detection, quantification and characterization of disseminated tumor cells].

    Acta medica Austriaca. Supplement·2003

    [Immunocytochemical and molecular detection of minimal residual disease in blood and bone marrow in colorectal cancer].

    Acta medica Austriaca. Supplement·2003

    [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].

    Acta medica Austriaca. Supplement·2003

    [Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer].

    Acta medica Austriaca. Supplement·2003
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us